Vexas syndrome was first discovered by American researchers less than a year ago. Now the doctors Jakob Werner Hansen and Niels Graudal at Rigshospitalet in Denmark have also identified the syndrome among the hospital’s patients, the newspaper writes BT.

Vexus syndrome is a very rare autoinflammatory disease that mainly affects middle-aged men over 50 years and up. Symptoms vary, and can range from connective tissue symptoms, unexplained fever, anemia, blood clots and inflammation of the use and lung tissue and blood vessels, skin changes and pain from the nose and ears.

Recognized the symptoms

According to BT, the discovery in Denmark came after doctor Werner Hansen read one scientific article on the syndrome and instant recognition many of the symptoms, which characterize the disease in own patients.

Several of the male patients at the hospital had in fact had a number of unexplained symptoms of illness, but without the doctors being able to ask and diagnose. After reading the article, Werner Hansen got the idea that it could be Vexas syndrome.

He then contacted Graudal, who specializes in rheumatology, and together they did their own research which showed that Danish men also suffer from the syndrome.

– So far, we have identified five Danish patients with the syndrome, but there are already several others to be examined, so we expect that there will be more, says Werner Hansen to BT.

Goes on the X chromosome

Researchers believe that only one frame of the syndrome can be used that can be used to sit on the X chromosome, which many have only one av. Researchers believe that women who have X chromosomes can tolerate one gene being affected because the other X chromosome provides a kind of protection, writes NBC News.

American research on the particular newly discovered disease shows that it has high mortality, but this may also be related to diagnosing is new, and therefore not something one can treat for yet.

– Right now, it is not any concrete treatment options, only medication that can alleviate symptoms. But in the future, we hope that it may be possible to replace bad stem cells if the disease becomes early and the patient can tolerate this type of treatment, says Werner Hansen.